BTIG Initiates Coverage On Vertex Pharmaceuticals, Notes Company's Cystic Fibrosis Therapies
January 05, 2015 at 19:11 PM EST
BTIG initiated coverage on Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Monday with a Buy rating and $200 price ...
